[ACRX] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
31-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- 236.06%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 651 1,771 2,818 5,416 2,289 2,151 7,995 -34.15%
PBT -10,287 47,768 -35,094 -40,375 -53,237 -47,147 -52,209 -23.70%
Tax 0 13 5 4 3 2 -701 -
NP -10,287 47,755 -35,099 -40,379 -53,240 -47,149 -51,508 -23.53%
Tax Rate - -0.03% - - - - - -
Total Cost 10,938 -45,984 37,917 45,795 55,529 49,300 59,503 -24.58%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -1,580.18 2,696.50 -1,245.53 -745.55 -2,325.91 -2,191.96 -644.25 16.12%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.00 5.73 -5.86 -9.47 -13.45 -16.14 -21.97 -
EPS Diluted -0.00 5.72 -5.86 -9.47 -13.45 -16.14 -21.97 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.